[ Clinicians Main Page ] [ V Book Sidebars ] [ V Book Endnotes ] [ Recent Journal References ]

Complete Endnotes from The V Book

[ Chapters 1-4 ] [ Chapters 5-7 ] [ Chapters 8-10 ] [ Chapters 11-13 ]
[ Chapters 14-15 ] [ Chapters 16-17 ] [ Chapters 18-19 ] [ Chapters 20-22 ]

Key To Journal Abbreviations

If you're interested in doing further research, the following is a list of medical journals I have cited in this text along with their abbreviations for easy reference. Some of these journals can be accessed for free online at the websites I've provided below (others require a paid subscription).

Chapter 20: The Lifetime Virus

  1. L. Corey, H. H. Handsfield, Genital herpes and public health: Addressing a global problem, JAMA 2000:283:791.
  2. B. J. Sullivan, Neonatal herpes simplex virus infections in King County, Washington: increasing incidence and epidemiologic correlations, JAMA 1983:256:3059.
  3. A. G. Nahmias, W. E. Josey, Epidemiology of herpes simplex viruses 1 and 2, in Viral Infections of Humans, Epidemiology and Incidence, A. S. Evans, ed. (New York: Plenum, 1982), 351.
  4. B. Raab, A. L. Lorinez, Genital herpes simplex—concepts and treatment, J Amer Acad Dermatol 1981:5:249.
  5. J. D. Oriel, Infective conditions of the vulva, in The Vulva, C. M. Ridley, S. M. Neill, eds. (London: Blackwell Science, 1999), 351.
  6. L. Corey, K. K. Holmes, Clinical course of genital herpes simplex virus infection in men and women, Ann Int Med 1983:48:973.
  7. L. Corey, W. C. Reeves, K. K. Holmes, Cellular immune responses in genital herpes simplex virus infections, N Engl J Med 1978:299:286.
  8. L. Koutsky, R. Ashley, et al., The frequency of unrecognized type 2 herpes simplex virus infection among women, Sexually Transmitted Dis 1990:17:90; J. F. Rooney, J. M. Felser, J. Ostrave, et al., Acquisition of genital herpes from an asymptomatic sexual partner, N Engl J Med 1986:314:1561.
  9. G. J. Mertz, O. Schmidt, R. Ashley, et al., Frequency of acquisition of first episode of genital infection with herpes simplex virus from symptomatic and asymptomatic contacts, Sexually Transmitted Dis 1985:12(1):83.
  10. S. N. Nader, C. G. Prober, Herpesvirus infections of the vulva and vagina, in Vulvovaginitis, P. Elsner, J. Martius, eds. (New York: Dekker, 1993), 229.
  11. B. Borck, S. Selk, J. Benedetti, et al., Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes, JAMA 1990:19:263; S. N. Nader, C. G. Prober, Herpesvirus infections of the vulva, Sem Dermatol 1996:15(1):8.
  12. M. K. Breinig, L. A. Kingsley, Epidemiology of genital herpes in Pittsburgh: Serologic, sexual and racial correlations of apparent and inapparent herpes simplex infection, J Infect Dis 1990:162:299; R. Johnson, A. Nahmias, L. Magder, et al., A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, N Engl J Med 1989:321:7; F. Bonchet, I. Yasukawa, R. Bronzan, et al., A prospective evaluation of primary genital HSV-2 infection acquired during pregnancy, Ped Inf Dis 1990:9:499.
  13. Corey, Holmes, Clinical course of genital herpes simplex virus infection.
  14. L. Corey, Genital herpes, in Sexually Transmitted Diseases, 2nd ed., K. K. Holmes, P.-A. Mardh, P. F. Sparling, P. J. Weisner, eds. (New York: McGraw-Hill, 1989), 391.
  15. Corey, Genital herpes.
  16. L. Corey, H. G. Adams, Z. A. Brown, et al., Genital herpes simplex virus infections: clinical manifestations, course and complications, Ann Int Med 1983:98:958.
  17. Nader, Prober, Herpesvirus infections of the vulva.
  18. W. E. Lafferty, R. W. Coombs, J. Benedetti, et al., Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type, N Engl J Med 1987:316:1444.
  19. W. C. Reeves, L. Corey, H. G. Adams, et al., Risk of recurrence after first episode of genital herpes: relation to HSV type and antibody response, N Engl J Med 1981:305:315.
  20. A. Mindel, D. Coker, et al., Recurrent genital herpes: clinical and virological features in men and women, Genitourin Med 1988:164:103.
  21. L. Corey, Genital herpes.
  22. Nader, Prober, Herpesvirus infections of the vulva.
  23. R. C. Moseley, L. Corey, D. Benjamin, et al., Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection, J Clin Microbiol 1981:13:918.
  24. R. Ashley, A. Cent, V. Maggs, L. Corey, Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus type 1 and 2, Ann Int Med 1991:115:520.
  25. A. Wald, New therapies and prevention strategies for genital herpes, Clin Infec Dis 1999:28(suppl 1):S4.
  26. Corey, Genital herpes.
  27. Wald, New therapies and prevention strategies.
  28. A. Wald, J. Benedetti, G. Davis, et al., A randomized, double-blind, comparative trial comparing high and standard dose oral acyclovir for first episode genital herpes infections, Antimicrob Agents Chemother 1994:38:174.
  29. Wald, New therapies and prevention strategies.
  30. G. R. Kinghorn, I. Abeywickreme, M. Jeavons, et al., Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes, Genitourin Med 1986:62:186.
  31. R. C. Reichman, C. J. Badger, G. J. Mertz, et al., Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial, JAMA 1984:251:2103.
  32. Nader, Prober, Herpesvirus infections of the vulva and vagina.
  33. Wald, New therapies and prevention strategies.
  34. J. M. Douglas, C. Critchlow, J. Benedetti, et al., Prevention of recurrent genital herpes simplex virus infection with daily oral acyclovir: a double-blind trial, N Engl J Med 1984:310:1551.
  35. K. H. Fife, C. S. Crumpacker, G. J. Mertz, et al., Recurrence and resistance patterns of herpes simplex virus following cessation of >6 years of chronic suppression with acyclovir, J Infect Dis 1994:169:1338; L. G. Kaplowitz, D. Baker, L. Gelb, et al., Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection: the Acyclovir Study Group, JAMA 1991:265:747; L. H. Goldberg, R. Kaufman, T. O. Kurtz, et al., Long-term suppression of recurrent genital herpes with acyclovir, Arch Dermatol 1993:129:582.
  36. L. Corey, R. Ashley, R. Sekulovich, et al., Lack of efficacy of a vaccine containing recombinant gD2 and gB2 antigens in MF59 adjuvant for the prevention of genital HSV-2 acquisition, in Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto) (Washington, D.C.: American Society for Microbiology, 1997).
  37. American Academy of Pediatrics, Herpes simplex, in G. Peter, ed., 1994 Red Book: Report of the Committee on Infectious Diseases, 23rd ed. (Elk Grove Village, Ill.: American Academy of Pediatrics, 1994), 242.
  38. K. M. Stone, C. A. Brooks, M. E. Guinan, et al., National surveillance for neonatal herpes simplex virus infections, Sex Transm Dis 1989:16:152.
  39. J. Sullivan Bolyai, H. F. Jull, C. Wilson, et al., Neonatal herpes simplex virus infection in King County, Washington: increasing incidence and epidemiologic correlates, JAMA 1983:250:3059.
  40. Z. A. Brown, S. A. Selke, J. Zeh, et al., Acquisition of herpes simplex virus during pregnancy, N Engl J Med 1997:337:509.
  41. L. L. Scott, P. J. Sanchez, G. L. Jackson, et al., Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes, Obstet Gynecol 1996:87:69.
  42. L. A. Vontver, D. E. Hickok, Z. A. Brown, et al., Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences, Am J Obstet Gynecol 1982:143:75.
  43. Z. A. Brown, L. A. Vontver, J. Benedetti, et al., Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic shedding, Am J Obstet Gynecol 1985:153:24.
  44. T. Lissauer, D. Jeffries, Preventing neonatal herpes infection, Br J Obstet Gynaecol 1989:96:1015.
  45. L. L. Scott, P. B. Sanchez, G. L. Jackson, et al., Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes, Obstet Gynecol 1996:87:69.
  46. B. Stray-Pedersen, Acyclovir in late pregnancy to prevent neonatal herpes simplex, Lancet 1990:336:756.
  47. Centers for Disease Control and Prevention, Pregnancy outcomes following systemic prenatal acyclovir exposure—June 1, 1984–June 30, 1993, MMWR 1993:42:806.
  48. A. S. Yaeger, Use of acyclovir in premature and term neonates, Am J Med 1982:73:205.

Chapter 21: The Crafty Virus

  1. T. V. Sedlacek, Advances in the diagnosis and treatment of human papillomavirus infections, Clin Obstet Gynecol 1999:42(2):206.
  2. American College of Obstetrics and Gynecology, Sexually transmitted diseases, in Precis V: An Update in Obstetrics and Gynecology (Washington, D.C.: ACOG, 1994), 87.
  3. G. Y. Ho, R. Bierman, L. Beardsley, C. H. Chang, R. D. Burk, Natural history of cervicovaginal papillomavirus infection in young women, N Engl J Med 1998:338:423.
  4. C. Volter, Y. He, H. Delius, et al., Novel HPV types present in oral papillomavirus lesions from patients with HIV infection, Int J Cancer 1996:66:453.
  5. K. R. Beutner, D. J. Wiley, J. M. Douglas, et al., Genital warts and their treatment, Clinical Infectious Diseases 1999:28(suppl 1):537.
  6. Beutner, Genital warts and their treatment.
  7. C. Sonnek, Human papillomavirus infection with particular reference to genital disease, J Clin Path 1998:51(9):643.
  8. Ibid.
  9. B. J. Monk, R. A. Burger, New therapies for genital condyloma in women, Contemporary ObGyn 1998 February:81.
  10. H. W. Buck and the Task Force on Human Papillomavirus Disease, Genital Human Papillomavirus (HPV) Disease: Diagnosis, Management, and Prevention (Rockville, Md.: American College Health Association, 1989).
  11. W. C. Phelps, K. A. Alexander, Antiviral therapy for human papillomavirus: rational and prospects, Ann Int Med 1995; 123(5):368.
  12. E. G. Friedrich Jr., Vulvar Disease (Philadelphia: W. B. Saunders Company, 1983), 194.
  13. L. Kjellberg, G. Wadell, F. Bergman, et al., Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser, Am J Obstet Gynecol 2000:183:1238.
  14. L. A. Koutsky, K. K. Holmes, C. W. Critchlow, et al., A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection, N Engl J Med 1992:327:1272.
  15. C. Ley, H. M. Bauer, A. Reingold, et al., Determinants of genital papillomavirus infection in young women, J Natl Cancer Inst 1991:83:997.
  16. K. Nasiell, V. Roger, M. Nasiell, Behavior of mild cervical dysplasia during long-term follow-up, Obstet Gynecol 1986:5:665.
  17. A. L. Herbst, Intraepithelial neoplasia of the cervix, in Comprehensive Gynecology, A. L. Herbst, D. R. Mishell, M. S. Stenchever, W. Droegemueller, eds. (St. Louis: Mosby–Year Book, 1992), 835.
  18. K. Nasiell, M. Nasiell, V. Vaclavinkova, Behavior of moderate cervical dysplasia during long-term follow-up, Obstet Gynecol 1983:61:609; Nasiell et al., Behavior of mild cervical dysplasia.
  19. Herbst, Intraepithelial neoplasia of the cervix.
  20. M. F. Mitchell, G. Tortolero-Luna, E. Cook, et al., A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix, Obstet Gynecol 1998:92:737.
  21. K. D. Hatch, N. F. Hacker, Intraepithelial disease of the cervix, vagina, and vulva, in Novak's Gynecology, J. S. Berek, E. Y. Adashi, P. A. Hillard, eds. (Baltimore: Williams & Wilkins, 1996), 447.
  22. D. E. Townsend, Cryosurgery for CIN, Obstet Gynecol Surv 1979:34:828.
  23. V. C. Wright, Carbon dioxide laser surgery for the cervix and vagina: indications, complications and results, Comprehensive Ther 1988:14:54.
  24. Hatch, Hacker, Intraepithelial disease of the cervix, vagina, and vulva.
  25. M. S. Baggish, Laser management of cervical intraepithelial neoplasia, Clin Obstet Gynecol 1983:26:968.
  26. T. C. Wright, S. Gagnon, R. M. Richart, A. Ferenczy, Treatment of cervical intraepithelial neoplasia using the loop electrosurgical excision procedure, Obstet Gynecol 1991:79:173.
  27. P. C. Gunasekera, J. H. Phipps, B. V. Lewis, Large loop excision of the transformation zone (LLETZ) compared to carbon dioxide laser in the treatment of CIN: a superior mode of treatment, Br J Obstet Gynaecol 1990:97:995.
  28. W. Prendiville, J. Cullimore, S. Norman, Large loop excision of the transformation zone (LLETZ): a new method of management for women with cervical intraepithelial neoplasia, Br J Obstet Gynaecol 1989:96:1989; P. F. Whiteley, K. S. Olah, Treatment of cervical intraepithelial neoplasia: experience with the low-voltage diathermy loop, Am J Obstet Gynecol 1990:162:1272.
  29. H. W. Jones, R. E. Butler, The treatment of cervical intraepithelial neoplasia by cone biopsy, Am J Obstet Gynecol 1980:137:882.

Chapter 22: V Cancer and Precancer

  1. J. S. Park, R. W. Jones, M. R. McLean, et al., Possible aetiological heterogeneity of vulvar intraepithelial neoplasia: a correlation of pathologic characteristics with human papillomavirus detection by in-situ hybridization and polymerase chain reaction, Cancer 1991:67(6):1599; E. J. Wilkinson, I. K. Stone, Atlas of Vulvar Disease (Baltimore: Williams & Wilkins, 1995).
  2. A. Singer, J. M. Monaghan, Lower Genital Tract Precancer (Boston: Blackwell Scientific Publications, 1994).
  3. E. G. Friedrich, E. J. Wilkinson, Y. S. Fu, Carcinoma in situ of the vulva: a continuing challenge, Am J Obstet Gynecol 1980:136:830.
  4. Ibid.
  5. C. Bergeron, Z. Naghashfar, C. Canaan, et al., Human papillomavirus type 16 in intraepithelial neoplasia (Bowenoid papulosis) and co-existent invasive carcinoma of the vulva, Int J Gynecol Pathol 1987:6:1.
  6. R. Li Vigni, A. Turans, M. Colombi, et al., Histological human papillomavirus-induced lesions: trypitzation by molecular hybridization techniques, Eur J Gynecol Oncol 1992:13(3):236.
  7. J. H. Dorsey, Understanding CO2 laser surgery of the vulva, Colposcopy & Gynecol Laser Surgery 1984:1(3):205–13; A. L. Kaplan, et al., Intraepithelial carcinoma of the vulva with extension to the anal canal, Obstet Gynecol 1981:58:368–71.
  8. Park et al., Possible aetiological heterogeneity of vulvar intraepithelial neoplasia; T. Toki, R. J. Kurman, J. S. Park, et al., Probable non-papillomavirus aetiology of squamous cell carcinoma of the vulva in older women: a clinico-pathological study using in-situ hybridization and polymerase chain reaction, Int J Gynecol Pathol 1991:10:107.
  9. R. W. Jones, M. R. McLean, Carcinoma in situ of the vulva: a review of 31 treated and 5 untreated cases, Obstet Gynecol 1986:68:499.
  10. J. D. Thompson, J. A. Rock, Te Linde's Operative Gynecology (Philadelphia: J. B. Lippincott, 1992).
  11. A. Singer, J. M. Monaghan, Lower Genital Tract Precancer (Boston: Blackwell Scientific Publications, 1994).
  12. Ibid.
  13. M. J. Campion, N. F. Hacker, Vulvar intraepithelial neoplasia and carcinoma, Semin Cutan Med Surg 1998 September:17(3):205; V. Kuppers, M. Stiller, T. Somville, H. G. Bender, Risk factors for recurrent VIN: role of multifocality and grade of disease, J Reprod Med 1997:42(3):140.
  14. Thompson, Rock, Te Linde's Operative Gynecology.
  15. R. W. Jones, D. M. Rowan, Vulvar intraepithelial neoplasia: III. A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma, Obstet Gynecol 1994:84:741.
  16. J. Fanning, L. Lambert, T. M. Hale, et al., Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision, Am J Obstet Gynecol 1999:180:24.
  17. P. J. DiSaia, W. T. Creasman, Clinical Gynecologic Oncology (St. Louis: Mosby Year Book, 1993), 263.
  18. Fanning et al., Paget's disease of the vulva.
  19. M. Sugase, T. Matsukara, Distinct manifestations of HPV in the vagina, Int J Cancer 1997 Jul 29:72(3):412.



.

        All rights reserved. Copyright © 2002 by Elizabeth G. Stewart, M.D.      Site design: www.gordonwithers.com and www.iilii.net